🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial.

N/A
0.241DataRank · unranked
4 citations

Qun Wu, Min Wu, Ping Lin

37 citations

Ping Lin, Qun Wu, Qinqin Pu, Chuan‐Min Zhou, Biao Wang +12 more

N/A
0DataRank · unranked
7 citations

Qun Wu, Biao Wang, Ping Lin, Min Wu, Xue-jie Yu +1 more

46 citations

Yongan Liu, Yuting Chen, Jinrong Hu, Wen Xiao, Xiaoshan Tang +13 more

27 citations

Luqing Cui, Yingying Liu, Rongpeng Li, Menghong Dai, Zhenwei Xia +2 more

98 citations

Shugang Qin, Qinqin Pu, Zhihan Wang, Qun Wu, Pan Gao +10 more

12 citations

Chuan‐Min Zhou, Qun Wu, Ping Lin, Qinqin Pu, Shugang Qin +8 more

42 citations

Biao Wang, Qun Wu, Ping Lin, Shugang Qin, Qinqin Pu +2 more